One team, multiple talents

Senior Associate Consultant

Michelle Saylor

Focus Therapy Area: Oncology, Neurodegenerative Diseases, Ophthalmology

Specialist Expertise: Diagnostics, Precision Medicine, Coverage and Reimbursement  

Education: Bachelor of Science from Brandeis University, with a concentration in Biology

What is your focus at Eradigm: My focus area at Eradigm is primarily market access which consists of elements that include commercial strategy and competitor and historic analysis. I work with a variety of stakeholders, industry giants to start-ups, that span across therapeutic areas.

What is your specialist expertise and what types of projects do you work on? I have both breadth and depth experience in multiple therapeutic areas that span from orphan drugs and rare diseases to more common spaces such as cancers and cardiovascular events. I assess market readiness through extensive research and perform additional analyses based on pricing, current coverage landscapes and competitive intelligence. Regardless of business questions or disease space, I always aim to deliver high-quality and solution-oriented work.

What did you do before Eradigm? Prior to Eradigm, I worked for a boutique healthcare consulting firm in Boston, MA. There, my focus was primarily commercial strategy, market access, and pricing and reimbursement.

What are your passions outside of work? I love all things having to do with food: cooking, eating, tasting, and enjoying meals with friends and family. I travel quite a bit and am working my way down my ever-expanding list of places to see. When I’m not travelling or munching, I like to read, watch documentaries, and play with my dogs.

Senior Associate Consultant

Sneha Chatterjee

Sneha joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her experience in infectious diseases research and a strive for contributing to global healthcare enhancement.

Sneha worked in consulting projects spanning therapeutic areas such as oncology, infectious diseases, haematology and rare diseases, and devices. She was involved in conducting competitive intelligence for multiple projects delivered on market assessment, data analytics, KOL profiling and social media analytics geographies including US, EU, LATAM and APAC markets. She was responsible for project management and driving multiple strategic intelligence engagements for year-long tracker projects to help clients understand and strategize their competition. She has also gained profound experience in collecting comprehensive market, competitor and stakeholder evidence through desk-based interviewing and elicitation; conducting research and analysing industry trends and data, create competitive landscape to understand the healthcare scenario, and comprehend reimbursement policies in global pharmaceutical market.

By qualification, Sneha is a medical microbiologist and obtained her PhD in infectious diseases with her research in the in overlapping fields of immunology and host-pathogen interaction, from the Medical University of Innsbruck, Austria. Her thesis decoded the role of Shiga toxin produced by Enterohemorrhagic E. coli (EHEC) in Haemolytic Uremic Syndrome (HUS). Prior to that, she secured her masters in Applied Microbiology from the VIT University, India, and bachelors in Microbiology (Honours) from the University of Delhi, India.

Outside of work, Sneha loves to travel and enjoys being acquainted with new cultures and trends. She loves to sing and has also lent her voice to a few short films as a playback singer. She is also trained in Indian dance forms, which she feels keeps her connected to her roots. Sneha loves to try out new cuisines and try her hands at cooking every once in a while.

Sneha believes in the idea of translational research with direct bench-to-bedside significance, and with her cumulative experience, would like to contribute to create a positive impact in the global healthcare space.

Senior Associate Consultant

Barney Poznansky

Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.

He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.

As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.  

Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research. 

Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.

Senior Associate Consultant

Emer Murphy

Emer contributes deep scientific expertise to the Eradigm team, where in her prior role she worked as a scientist on early-stage drug discovery projects with the CRUK-Astra Zeneca drug discovery alliance. This work included strategic planning of accelerated projects, managing external collaborations, and identifying new potential targets for immunooncology assets. 

Emer’s has a BSc. in Human Genetics from University College Cork, Ireland, where her focus aimed to identify the heritability of Psychosis disorders. Following this, she went on to complete an MSc. in Molecular Medicine from the University of Leeds. In her Master’s research, Emer investigated the effect of a novel small molecule inhibitor in comparison to, and in combination with, standard of care chemotherapy in childhood Ewing’s Sarcoma on primary samples from St James University Hospital in Leeds. 

Outside of work, Emer enjoys cooking, writing her food blog, making her way through the best restaurants in London and running in Victoria Park to counteract all of that. Emer enjoys reading Scandi Noir novels, while trying to keep her houseplants alive.  

Senior Associate Consultant

Jessica Timms

Jessica holds a PhD in Cancer Epigenetic Epidemiology from Newcastle University, her project focused on DNA methylation as a potential mediator of early life exposures and the risk of childhood acute lymphoblastic leukaemia (ALL). During her PhD, she worked both in the laboratory and carried out computational analyses, collaborating with different faculties within Newcastle University and Bristol University. Throughout her PhD and post-doc position, Jessica taught molecular, genetic, epigenetic, and epidemiological modules on MSc courses at Newcastle University and supervised and assessed undergraduate/postgraduate students. Additionally, Jessica spent 3 years as a post-doctoral researcher at King’s College London, where her focus was in immune-oncology and computational biology, projects included exploring immune regulation and dysregulation in myeloproliferative neoplasms and myelodysplastic syndromes; and COVID-19 patient immune response to Baricitinib: can we predict immune dysregulation?

Since moving into life sciences consulting, Jessica has been part of, and led a variety of projects, mostly focused on oncology (both heme and solid tumours). Her experience includes data collection and interpretation, designing deliverables, leading client updates, deep-dives, attending conferences, delivering ad-hoc requests, and conducting comprehensive and robust primary and secondary market research. Experience in compiling competitive intelligence for novel therapeutics, including a thorough assessment of the commercial landscape, unmet needs, and market positioning. Additionally, Jessica has designed and run workshops to help clients understand competitors, pressure test assumptions, and gain deeper insight into the scientific aspects of their projects. Jessica has experience with healthcare systems in multiple geographies, including the US and EU.

Outside of work, Jessica loves to explore, whether it is a different country and culture or different parts of the UK, especially trekking through beautiful landscapes. Jessica is also a huge lover of music and spends a lot of time at gigs, events, or festivals.

Senior Associate Consultant

Oliver Odell

Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.

Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.

Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.

Senior Associate Consultant

Nadeen Solaiman

Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.

Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.

Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.

Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.  

Senior Associate Consultant

Paula Wegbrans Giro

Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.

Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.

Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.

Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.

Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people. 

Senior Associate Consultant

Kelly Choong

Kelly joined Eradigm in June 2022 as an Associate Consultant, bringing to the team her experience in medical communications and scientific publishing, and her passion for advancing healthcare research. 

Kelly previously worked in medical communications as an Account Executive, where her role largely involved project and client management. She worked with pharmaceutical companies on a range of projects related to Medical Affairs, which were used to train field medical teams in the Respiratory and Infections department. Prior to this, Kelly worked at an open access scientific publisher as a Journal Launch Specialist. This role involved extensive liaison with academics and building editorial boards. As a result, she launched two new journals in Engineering and Health Sciences, and multiple sections within existing journals. 

Kelly completed both her BSc and MScR at Durham University in Biomedical Sciences. Her master’s thesis in Tissue Engineering was titled ‘Investigating the deposition of the extracellular matrix and bone tissue development in vitro using 2D and 3D cell culture methods’. The laboratory-based study investigated the use of a 3D scaffold to culture bone forming cells, in order to develop an in vitro bone tissue model which could then ultimately be used to model diseases such as osteoporosis. Kelly gained extensive experience in the lab, learning techniques such as mammalian cell culture, histology and stem cell differentiation.  

Outside of work, Kelly likes to cook and experiment with new recipes. She is always on the lookout for new restaurants to try and welcomes any recommendations. She enjoys exploring nature and watching sitcoms in her free time. 

Senior Associate Consultant

Liam Maddison

As Liam joins Eradigm in July 2022 as an Associate Consultant, he brings a wealth of early-stage therapeutic discovery expertise following the completion of his industry-partnered PhD programme. He has a keen interest in the application of disruptive technologies within the healthcare landscape and a desire to work with key stakeholders to revolutionise current treatment paradigms.

Undertaking his PhD research at The University of Leeds, Liam spearheaded an early-stage drug discovery campaign against a prominent epitranscriptomic regulator, with the promise to meet unmet needs in oncology and virology. The project identified a collection of novel hits against the target, culminating in the development of a potent lead compound that will be the subject of further optimisation, laying the groundwork for therapeutic development. Throughout this project, Liam managed a multi-centre collaboration and worked closely with scientists and leadership at his pharmaceutical partner company.

During his PhD studies, Liam nurtured a growing interest in the commercial aspects of the Life Sciences sector, competing in national entrepreneurship competitions and securing freelance consulting work to enhance his skillset. Here, he worked alongside top 20 pharma clients to hone his CI skills, conducting market research and conference monitoring across the cell therapy and HIV landscapes.

Prior to this, Liam completed an integrated master’s degree in Medicinal chemistry at the University of Leeds, where he discovered an interest in the pharmaceutical industry and developed expertise in small molecule drug development.

In his free time, Liam enjoys getting outdoors as much as possible, whether that be backpacking, hiking or trail running. When not out in nature, you will most likely find him anxiously watching Newcastle United, listening to his vinyl record collection, or kicking back with a good book.

Senior Associate Consultant

Sean Abbott-Imboden

Sean joined Eradigm as an Associate Consultant in August 2022, bringing to the team his prior experience in healthcare consultancy, medical communications and data management.

Sean previously worked at a boutique life sciences consulting firm, where his role centred on conducting primary and secondary research to identify key market events and trends to support pharmaceutical companies’ strategy. Sean has worked with a plethora of pharmaceutical companies across a range of therapeutic area specific projects and cross-portfolio workstreams. Prior to this, Sean worked in Data Management for a top-10 clinical research organisation where he was responsible for reconciling and analysing clinical trial data, maintaining study documentation, and performing quality control audits of clinical trial databases.

Sean holds a BSc in Biomedical Sciences from the University of Warwick which provided him with a platform to pursue his MSc in Cancer Biology at University College London (UCL). His MSc (Distinction) consolidated his skills in critically evaluating primary and secondary scientific literature, experimental planning and interpretation of results. Diverging away from his oncology background to supplement his knowledge and support broader research efforts, his MSc dissertation focused on developing a computational in-silico model to identify drug combinations to fight COVID-19. His work contributed to a scientific publication in Nature Partner Journals – Digital Medicine.  

Sean’s academic and professional experiences have provided him with a deep understanding of the commercial and therapeutic landscape across oncology, neurology and COVID-19 as well as continually emerging fields such as digital healthcare.

Outside of work, Sean is a huge sports enthusiast. He is particularly keen on playing football, running, going to the gym and skiing. He also enjoys travelling and spending time with friends and family.

Associate Consultant

Zain Aziz

Zain joined Eradigm in May 2022 as an Associate Consultant bringing to the team his curiosity for the life sciences and passion for global healthcare.

Prior to joining Eradigm, Zain has worked in consulting projects with different healthcare providers across Europe aiding in their digital transformation process and the implementation of electronic patient healthcare record systems. His focus was mainly within clinical research organisation, and he was heavily involved with advising clients as to how to identify potential opportunities to increase recruitment onto clinical studies, as well as increasing patient study visibility for trust members, with the end goal to provide better overall care for patients being treated.

Zain holds a BSc and PhD in Biomedical Sciences and Biotechnology, respectively from the University of Westminster. His research was focused on the development of novel fermentation strategies to increase the production of bioplastics through the manipulation bacterial communication circuits. During his PhD, Zain was also able to acquire a professional development qualification in learning and teaching within the
Higher Education Academy, U.K.

Outside of work, Zain is an avid hiker and frequent gym-goer who loves to travel and visit new places. In his free time, he enjoys exploring London’s live music offerings and carrying out DIY projects.

Associate Consultant

Kamaal Lynch-Samms

Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.

He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.

During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.

In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.

Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.

Associate Consultant

Shreya Murali

Shreya joined Eradigm in April 2021 as an associate consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.

Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.

Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.

In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.

Associate Consultant

Bianka Roka

Bianka holds a First-Class Honours degree in business management from Queen Mary, University of London, where she studied the principles of economics, accounting, and organisational behavior.

A year spent at Cornell University as an exchange student further enriched her academic palette, exposing her to subjects like cognitive science, ethical decision-making in management, and negotiations. Transitioning into the world of data, Bianka pursued her first master’s degree in Data Science with Bioinformatics at the University of Durham. While her coursework covered practical applications of computational methodologies, her independent research focused on critically evaluating the ethical implications of emerging AI-enabled technologies. This technical foundation seamlessly transitioned into her second master’s degree, an MPhil in Translational Neuroscience at the University of Cambridge. Here, she led a computational psychiatry project, employing machine learning models to predict autism spectrum disorders from prenatal data. Alongside this, she developed a deep interest in nutritional psychiatry and the microbiome’s crucial role in health.

Bianka also participated in an external consulting project with an NGO, where she was tasked with identifying key demographic trends and donor behaviours with regards to charitable giving.

Outside of work, she enjoys playing sports, especially tennis and golf. She also likes taking long walks in different London neighbourhoods and often stops for an iced coffee during her strolls.

Associate Consultant

Isaac Bryan

Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research. 

In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.

Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk. 

Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.

Associate Consultant

Joshua Wyatt

Joshua joined Eradigm in September 2022 as an Associate Consultant, bringing his relevant academic and professional experience alongside.

Joshua holds an Honours BSc from the University of Toronto in Canada, from a joint program with the School of the Environment and the Department of Pharmacology and Toxicology within the Faculty of Medicine. Here, Joshua discovered his interest in chemical pollutants, antibiotic resistance, and climate change. In the midst of his undergrad, Joshua participated on an academic exchange to the University of Amsterdam, Netherlands, where he gained a global view on the pharmaceutical industry. Further his studies, Joshua went forth to complete a Masters degree in Drug Discovery and Pharma Management at the UCL School of Pharmacy in London, England. In his dissertation, Joshua studied the recent trends in Alzheimer’s disease drug development and clinical trial research, and discovered important findings in the commercial operations of the neurodegenerative disease space.

Alongside his undergraduate studies, Joshua worked at a small toxicological research organization, contributing to reports and datasets on various chemicals around the globe, and how they bioaccumulate within different species and their food systems. Alongside his graduate dissertation, Joshua worked an internship with Clarivate Analytics, where he learned a vast amount about life science consulting, and the various projects, deliverables, and resources many different companies require to advance their pipeline and revenue.

Outside of academia and work, Joshua coached local swim teams and helped organize community events around Toronto, making great friends and memories along the way. In his spare time, Joshua loves to cycle around the countryside, play basketball with friends, and practice his musical instruments.

Associate Consultant

Aravind Kumar

Aravind joined Eradigm as an Associate Consultant in July 2023.

He holds a BSc in Natural Sciences from the University of Leeds, specialising in Biochemistry. His dissertation involved an extensive literature review to investigate the molecular features of pandemic viruses. Following this, Aravind completed his MSc at UCL in Experimental and Translational Immunology. His MSc research project focused on the role of the B-cell adapter protein (BCAP) on primary immunodeficiencies.

Since completing his studies, Aravind has worked at Inpharmation, a firm that specialises in pharmaceutical pricing and forecasting. During his time there, he engaged in various projects in a number of therapeutic areas, including neurological disorders, bleeding disorders, and oncology.

In his spare time, Aravind enjoys playing sports, specifically golf, tennis, and cricket. He is also a keen chef, and loves experimenting with different cuisines.

Associate Consultant

Madina Khusnullina

Madina joined Eradigm as an Associate Consultant in July 2023, bringing her academic research experience and passion for Life Sciences industry to the team.

In her previous job Madina was conducting research and analysis of fine chemicals industry in the UK, working alongside world-class academics at Imperial College. She holds a Master’s degree with Distinction in International Health Management from Imperial College London, which provided her with commercial awareness and practical knowledge in health economics, business and marketing for healthcare and pharmaceutical companies.

Prior to this, Madina graduated from University College London with BSc Pharmacology, where she developed extensive knowledge and expertise in biomedicine and drugs. Her dissertation was focused on researching potential physiological targets for treatment of endothelial dysfunction, a type of non-obstructive coronary artery disease. Madina also completed an internship in consulting within sustainability, which encouraged her to pursue her career in consulting industry.

In her free time, Madina enjoys playing tennis, singing, exploring museums and hanging out with friends. She is also passionate about food and different cuisines, so cooking and baking provide her with space for creativity.

Associate Consultant

Eleanor Hollis

Eleanor joined Eradigm as an Associate Consultant in September 2023, bringing with her experience in market research and a passion for healthcare. In her previous role, she focused on health economics, project management, and primary and secondary research for large pharmaceutical companies and small biotech. Eleanor has experience utilising a breadth of research techniques to help support clients’ submissions to HTA bodies and product lifecycle management.

Eleanor holds a BSc Honours in Pharmacology from The University of Southampton. During this programme, she evaluated the potential of a new disease-modifying treatment for Alzheimer’s Disease. Eleanor’s interest and passion for healthcare systems and pharmaceutical development led her to purse a MSc in Pharmaceutical Formulation and Entrepreneurship at UCL. In her MSc dissertations, she formulated a 3D printed multi-drug-loaded suppository for the treatment of acute severe ulcerative colitis in addition to assessing its commercial feasibility in a business case analysis. As a result, Eleanor has become passionate about the development of personalised medicines and processes to support the efficiency of healthcare systems.

Outside of work, she is an avid runner and frequent gym-goer who loves to run to new coffee and pastry shops on the weekend and will always try and persuade others to join her. In her free time, she also enjoys cooking, spending time with friends and exploring new places.

Associate Consultant

Tiya Ravindran

Tiya joined Eradigm in July 2023 as an Associate Consultant, bringing to the team her passion for advancing healthcare research and prior experiences working in PR, medical communications, and digital health start-ups.

Previously, Tiya was a PR consultant managing several pharmaceutical clients and various projects, spanning therapeutic areas including neurology, immunology, orthopaedics, dermatology, and women’s health. Tiya was involved in advising clients with their communications strategy during key congresses, on data communications and competitive insights, developing high-quality HCP and patient materials, and managing relationships with patient advocacy groups and multiple external stakeholders.

Tiya holds a BSc in Biological Sciences from the University of Leicester, where she studied Neuroscience and focused her dissertation and research interests in maternal health and child neurodevelopment. Tiya studied for her MSc at University College London (UCL), in Bioscience Entrepreneurship, where she developed her expertise in the intersection between life sciences and research commercialisation. During her post-graduate studies, Tiya worked at digital health start-ups which intend to disrupt and transform standard healthcare and medicine, through innovations in digital technology. At Syrona Health, spinout FemTech company from University of Cambridge, Tiya developed an in-app digital tool for personalised contraception with a focus on limiting side effects. Tiya was also part of the 2021 Entrepreneur In Residence cohort for idea incubation in European healthcare, with SanusX UNIQA, a leading insurance provider in CEE.

From her experiences in medical communications, working at MedTech startups, and her studies, Shakitiya hopes to continue expanding her knowledge in the fields of entrepreneurship, science communication, healthcare and research.

Outside of work, Tiya likes to keep active with weight-lifting, salsa-dancing, Muay Thai, and swimming. Passionate about exploring new cultures, Tiya enjoys travelling around the world, meeting new people, and experiencing local cuisines.

Associate Consultant

Sara Ahmad

Sara joined Eradigm in August 2023 as an Associate Consultant. With an impressive background as a Scientist in cell therapy, Sara brings a wealth of experience that will play a pivotal role in bridging the gap between research & development and innovation within the organisation.

Previouly, Sara worked as one of the very first R&D members at Mogrify, a biotech start-up at the Cambridge Science Park. During her four-year tenure, she developed expertise in pre-clinical strategy decision making regarding delivery methods such as AAVs, IVTs, and Lentivirus. She also worked across various teams (chondrocytes, ophthalmology and immunology) where her data influenced the business strategy. Sara has first-hand experience of the challenges and triumphs that come with establishing a biotech company. 

In 2019, Sara graduated with a 1st class honors Biomedical Science degree from the University of Westminster, where she engaged in extensive CRISPR-related work during her undergraduate project. With her academic achievements, Sara embarked on a journey of continual growth, determined to make a difference in the world of regenerative medicine, drug discovery and beyond. 

Outside of work, Sara loves reading and writing poetry. She is always hunting for open mic events where she can be inspired by other poets. Sara has a passion for teaching Arabic to children. Embracing her heritage, Sara has recently started learning how to play the Oud.

Sara is committed to excellence. She is ready to seize every opportunity and tackle challenges head-on in her role as an Associate Consultant at Eradigm.

Associate Consultant

Amy Murray

Amy joined Eradigm in August 2023 as an associate consultant, bringing to the team her extensive experience in pharmaceutical market research and passion for transforming healthcare globally.

Amy previously worked at a data intelligence and consulting company, where her role was centred around conducting primary and secondary market research within the cardiovascular, metabolic disorders, and gender health spaces. She was responsible for producing syndicated market research reports and drug sales forecasts on therapeutic areas including endometriosis and atrial fibrillation, providing clients with strategic insights and high-quality market analysis. Prior to this, she also completed an internship at a life science strategy consulting firm, where she worked with pharmaceutical companies and biotech start-ups across a range of therapeutic area-specific projects.

Amy holds a first-class honours degree in neuroscience from UCL, where she developed a strong interest in neuropharmacology and the development of therapeutics for complex neurodegenerative diseases. Her final year dissertation focused on researching potential drug targets aimed at promoting neuroplasticity and enhancing motor recovery following ischemic stroke. Following this, Amy went on to complete her MSc in Drug Discovery and Pharmaceutical Management at UCL, where she gained extensive insight into the whole drug development process, from the initial drug target identification stages through to drug commercialisation and regulatory affairs. Her final research project analysed recent trends in the biotech financing environment, with a particular focus on IPOs.

In her free time, Amy enjoys playing tennis, trying out new fitness classes with friends, and attending the occasional park run on a Saturday morning. She also loves any food-related activities, whether that be exploring restaurants around London, or hosting friends and family for dinner where she can test out new recipes!

Associate Consultant

Megan Murdoch

Megan joined Eradigm in August 2023 as an Associate Consultant, bringing an interest in transformative technologies for improving healthcare and research experience ranging from regenerative medicine to digital health technologies.

Megan has a BSc in Biological Sciences (Biotechnology) from the University of Edinburgh, where she studied medical, agricultural, molecular, and industrial biotechnology. Her dissertation focused on the development of hydrogels for tissue engineering. Megan then studied for an MPhil in Bioscience Enterprise at the University of Cambridge. This multidisciplinary biotech and business course focused on teaching strategy, healthcare economics, venture financing and valuations, intellectual property, and trends in biotechnology. It included an external consulting project with an AI drug discovery start-up, where Megan was tasked with identifying the current trends in small-molecule combination therapy deals. Megan also worked with a digital health start-up for her final dissertation. Her dissertation investigated ADHD Care in the Digital age, identifying the market and demand for children’s digital health technologies. This research aimed to advise the start-up on key risks and interest areas in digital ADHD Care. Megan looks forward to expanding her knowledge of entrepreneurship and the regulatory process for novel technologies.

In her free time, Megan enjoys running, going to the gym, visiting museums and galleries, and spending time with friends. She also enjoys trying new coffee shops and pastries.

Associate Consultant

Estela Ioannidou

Estela joined Eradigm in September 2023 as an Associate Consultant, bringing her enthusiasm for aiding healthcare companies in advancing and commercializing therapies, coupled with her professional and academic achievements in the life sciences.

Previously, Estela worked at GLG, supporting multiple clients across the pharmaceutical and diagnostic industries to connect with key experts and stakeholders across the product lifecycle. Here, Estela built commercial and industry knowledge, by working on projects across multiple therapeutic areas and stages of development. 

Estela holds a BSc in Biomedical Sciences from University College London, which included a neuroscience research project, specifically on the molecular programming of MGE-derived cortical interneurons. Estela also holds an MSc in Genes, Drugs, and Stem Cells – Novel Therapies from Imperial College London, where she explored the cell and gene therapy landscape, and conducted research on the role of key miRNAs in ischaemic heart disease and diabetes. 

From her experience at GLG and university degrees, Estela hopes to get one step closer to supporting healthcare clients with product commercialisation, and helping patients get access to treatments.

In her free time, Estela enjoys sewing, reading, listening to true crime podcasts, swimming, and going to the gym.